Skip to content

Analgesic Efficacy of Transmuscular Quadratus Lumborum in Patients Undergoing Total Abdominal Hysterectomy

Transmuscular Quadratus Lumborum Block for Postoperative Pain After Total Abdominal Hysterectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02586454
Enrollment
64
Registered
2015-10-26
Start date
2015-11-30
Completion date
2017-01-31
Last updated
2017-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Postoperative

Keywords

Transmuscular quadratus lumborum block, total abdominal hysterectomy

Brief summary

Patients who have undergone laparotomies often require multimodal postoperative pain regimes. In recent years, abdominal wall blocks have been included to become part of this in order to overcome side effects of systemic opioids and complications from epidural analgesia. Borglum popularised a new approach on abdominal wall blocks by introducing the transmuscular quadratus lumborum (QL) block. Transmuscular QL block is thought to be effective against somatic and visceral pain as local anaesthetic tends to spread from the site of injection to thoracic paravertebral spaces where the sympathetic chain lies. The objective of this study is to evaluate the analgesic efficacy of transmuscular QL block in patients undergoing total abdominal hysterectomy (TAH) by measuring cumulative opioid consumption, pain score at rest and on movement 24 hours after TAH. Our hypothesis is patients given transmuscular QL block will have lower cumulative opioid consumption.

Interventions

DRUGmorphine
DRUGropivacaine

Sponsors

Kuala Lumpur General Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. ASA I or II 2. Patient's weight \> 50kg 3. Elective TAH

Exclusion criteria

1. Body mass index (BMI) \> 35 kg/m2 2. Any contraindications to peripheral nerve blocks i.e. local skin infection, coagulopathy, allergy to LA 3. Inability to use patient controlled analgesia 4. Patient on antiplatelet, anticoagulant or on regular use of opioids, paracetamol, nonsteroidal anti-inflammatory drugs or tramadol for chronic condition

Design outcomes

Primary

MeasureTime frameDescription
Cumulative morphine consumption24 hours after total abdominal hysterectomyin mg for 24 hours
Pain score at rest and movement24 hours after total abdominal hysterectomyusing visual analogue scale 1 to 10

Secondary

MeasureTime frameDescription
Complications related to the transmuscular QL block24 hours after total abdominal hysterectomyComplications related to transmuscular QL block: Haematoma at site of injection,infection at site of injection Complications related to PCAM:Nausea, vomiting, pruritus, sedation

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026